# Seaweed Extract Supplementation and Metabolic Biomarkers

> **NCT03853343** · NA · COMPLETED · sponsor: **BioAtlantis Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Metabolic Syndrome
- Insulin Sensitivity

## Interventions

- **DIETARY_SUPPLEMENT:** Seaweed extract
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03853343
- **Lead sponsor:** BioAtlantis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2020-01-30
- **Final completion:** 2022-01-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03853343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03853343, "Seaweed Extract Supplementation and Metabolic Biomarkers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03853343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*